Central Nervous System Agents in Medicinal Chemistry
Title: Editorial [Hot Topic: Recent Advances in Stroke: Molecular Mechanisms, Approaches, and Treatments (Guest Editor: Xin Wang)]
Volume: 11 Issue: 2
Author(s): Xin Wang
Affiliation:
Export Options
About this article
Cite this article as:
Wang Xin, Editorial [Hot Topic: Recent Advances in Stroke: Molecular Mechanisms, Approaches, and Treatments (Guest Editor: Xin Wang)], Central Nervous System Agents in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/187152411796011385
DOI https://dx.doi.org/10.2174/187152411796011385 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development
Current Medicinal Chemistry Ca<sub>v</sub>1.3 Channels as Key Regulators of Neuron-Like Firings and Catecholamine Release in Chromaffin Cells
Current Molecular Pharmacology Release Kinetics of Calcium and Quercetin from Chewing Gum as a Novel Antiplaque and Antimicrobial Device
Current Drug Delivery Identification of Novel Pancreatic Lipase Inhibitors Using <i>In Silico</i> Studies
Endocrine, Metabolic & Immune Disorders - Drug Targets Colloid Update
Current Pharmaceutical Design Cardiac and Metabolic Consequences of Aerobic Exercise Training in Experimental Diabetes
Current Diabetes Reviews Premature Adrenarche and its Association with Cardiovascular Risk in Females
Current Pharmaceutical Design Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging The Role of α5 GABA<sub>A</sub>Receptor Agonists in the Treatment of Cognitive Deficits in Schizophrenia
Current Pharmaceutical Design Effect of ABCB1 Genotypes on the Pharmacokinetics and Clinical Outcomes of New Oral Anticoagulants: A Systematic Review and Meta-analysis
Current Pharmaceutical Design Carbohydrate-Based Drugs in the Treatment of Epilepsy, Depression and Other Affective Disorders
Current Topics in Medicinal Chemistry Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes
Current Drug Targets Therapeutic Drugs in Bone Loss-Associated Disorders: Clinical Outcomes and Challenges
Current Drug Targets Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials Review of Trans-Atlantic Cardiovascular Best Medical Therapy Guidelines – Recommendations for Asymptomatic Carotid Atherosclerosis
Current Vascular Pharmacology Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer
Current Pharmaceutical Design Synthetic Glycosides and Glycoconjugates of Low Molecular Weight Natural Products
Current Pharmaceutical Design Chronic Kidney Disease and Urological Disorders: An Overview
Current Signal Transduction Therapy Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Comparison of Dapaglifozin and Liraglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial
Endocrine, Metabolic & Immune Disorders - Drug Targets